Company · CIK 0001513525 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ADIAL PHARMACEUTICALS, INC. · ADIL
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 PForm 4 → | Jul 16, 5:08 pm EDT | Coastlands Capital LP10% Owner | 3,233 | $2.69 | $8,691 | 388,308 | +0.84% | |
| Jul 9, 2026 PForm 4 → | Jul 13, 10:30 am EDT | Coastlands Capital LP10% Owner | 11,753 | $2.78 | $32,638 | 385,075 | +3.15% | |
| Jun 29, 2026 PForm 4 → | Jul 1, 10:30 am EDT | Coastlands Capital LP10% Owner | 25,000 | $2.60 | $65,000 | 373,322 | +7.18% | |
| Jun 11, 2026 AForm 4 → | Jun 16, 6:36 am EDT | Matt DavidsonChief Development Officer, Director | 299,414 | — | — | 1,923 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 AForm 4 → | Sep 21, 7:25 pm EDT | Wendy B. YoungDirector | 25,666 | — | — | 25,666 | — | |
| Jun 12, 2026 AForm 4 → | Jun 16, 6:36 am EDT | Matt DavidsonChief Development Officer, Director | 232,417 | — | — | 232,417 | — | |
| Jun 12, 2026 PForm 4 → | Jun 16, 6:14 am EDT | Wendy B. YoungDirector | 36,378 | $2.75 | $99,999 | 36,378 | — |